(Q42417784)

English

Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey

scientific article published on 22 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey (English)

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

1 reference

based on heuristic

inferred from title

commercialization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David C Klonoff

1

object named as

David Klonoff

1 reference

Europe PubMed Central

30 October 2017

PMC publication ID

author name string

Irina Nayberg

2

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Frank Erbstein

3

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Anna Cali

4

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Claire Brulle-Wohlhueter

5

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Thomas Haak

6

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

publication date

22 May 2015

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Journal of Diabetes Science and Technology

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

9

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

936-938

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4525641

28 May 2018

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4525641

28 May 2018

What can we learn from patient-reported outcomes of insulin pen devices?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4525641

28 May 2018

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4525641

16 August 2018

New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/26002837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1932296815586219

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42417784&oldid=1944419543"